Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.
Fehily SR, Al-Ani AH, Abdelmalak J, Rentch C, Zhang E, Denholm JT, Johnson D, Ng SC, Sharma V, Rubin DT, Gibson PR, Christensen B. Fehily SR, et al. Among authors: ng sc. Aliment Pharmacol Ther. 2022 Jul;56(1):6-27. doi: 10.1111/apt.16952. Epub 2022 May 20. Aliment Pharmacol Ther. 2022. PMID: 35596242 Free PMC article. Review.
Emerging biologics in inflammatory bowel disease.
Chan HC, Ng SC. Chan HC, et al. Among authors: ng sc. J Gastroenterol. 2017 Feb;52(2):141-150. doi: 10.1007/s00535-016-1283-0. Epub 2016 Nov 10. J Gastroenterol. 2017. PMID: 27832357 Review.
Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment.
Park DI, Hisamatsu T, Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK. Park DI, et al. Among authors: ng sc. J Gastroenterol Hepatol. 2018 Jan;33(1):20-29. doi: 10.1111/jgh.14019. J Gastroenterol Hepatol. 2018. PMID: 29023903 Review.
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management.
Park DI, Hisamatsu T, Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK. Park DI, et al. Among authors: ng sc. J Gastroenterol Hepatol. 2018 Jan;33(1):30-36. doi: 10.1111/jgh.14018. J Gastroenterol Hepatol. 2018. PMID: 29024102 Review.
A Global Survey of Gastroenterologists' Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas.
Chan W, Shim HH, Ng SC; Asia–Pacific Crohn’s and Colitis Epidemiologic Study (ACCESS) Study Group; Liu J, Inglis C, Greveson K, Baraty B, Haifer C, Leong RWL. Chan W, et al. Among authors: ng sc. J Crohns Colitis. 2018 Nov 15;12(11):1261-1269. doi: 10.1093/ecco-jcc/jjy110. J Crohns Colitis. 2018. PMID: 30215692
1,153 results